Agency Information Collection Activities: Proposed Collection; Comment Request, 53480-53482 [2022-18801]
Download as PDF
<![CDATA[
53480
Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices
Authority: Section 520A of the Public
Health Service Act, as amended.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022–18802 Filed 8–30–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2022 Notice of
Supplemental Funding Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award
supplemental funding.
AGENCY:
This is a notice of intent to
award supplemental funding to the 13
Mental Health Technology Transfer
Center (MHTTC) Cooperative
Agreement recipients funded in FY
2018 under Funding Opportunity
Announcement SM–18–015. This is to
inform the public that the Substance
Abuse and Mental Health Services
Administration (SAMHSA) is
supporting one-year administrative
supplements up to $304,081 per
recipient.
This supplement will provide
continued direct technical assistance
(TA) and training on the
implementation and delivery of mental
health services in schools and school
systems, including training and TA
provided to Project AWARE grantees.
This will involve not only TA to the
general field but provision of direct and
tailored TA to grantees on school-based
mental health services implementation.
This is not a formal request for
application. Assistance will only be
provided to the Mental Health
Technology Transfer Center Cooperative
Agreement grant recipients based on
receipt of a satisfactory application and
associated budget. These recipients
were funded in FY 2018 under the
Mental Health Technology Transfer
Center Cooperative Agreement Funding
Opportunity Announcement SM–18–
015 with a project end date of August
29, 2023.
SUPPLEMENTARY INFORMATION:
Funding Opportunity Title: FY 2018
Mental Health Technology Transfer
Center Cooperative Agreements, SM–
18–015.
Assistance Listing Number: 93.243.
Authority: Section 520A of the Public
Health Service Act, as amended.
Justification: Eligibility for this
supplemental funding is limited to the
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:59 Aug 30, 2022
Jkt 256001
13 Mental Health Technology Transfer
Center Cooperative Agreement
recipients that were funded in FY 2018
under the Mental Health Technology
Transfer Center Cooperative Agreement
(SM–18–015). The recipients have
unique and special expertise in
accelerating the adoption and
implementation of mental health-related
evidence-based practices; heightening
the awareness, knowledge, and skills of
the workforce that addresses the needs
of individuals with serious mental
illness or serious emotional disturbance;
fostering regional and national alliances
among culturally diverse practitioners,
researchers, policy makers, family
members, and consumers of mental
health services; and ensuring the
availability of training and technical
assistance to SAMHSA/Center for
Mental Health Services grant recipients.
The MHTTCs are uniquely positioned to
coordinate and manage SAMHSA’s
national efforts to ensure that high
quality, effective mental health
treatment and recovery support services,
and evidence-based practices are
available for all individuals with mental
disorders, especially those with serious
mental illness or serious emotional
disturbance.
Contact: Kimberly Reynolds,
Substance Abuse and Mental Health
Services Administration, 5600 Fishers
Lane, Rockville, MD 20857, telephone
(240) 276–2825; email:
Kimberly.reynolds@samhsa.hhs.gov.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022–18800 Filed 8–30–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
0361.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Comments are invited on: (a) whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: ‘‘Notification of
Intent To Use Schedule III, IV, or V
Controlled Medications for the
Treatment of Opioid Use Disorder’’
Under 21 U.S.C. 823(g)(2) (OMB No.
0930–0234 and OMB No. 0930–0369)—
Revision
The Drug Addiction Treatment Act of
2000 (‘‘DATA,’’ Pub. L. 106–310)
amended the Controlled Substances Act
(21 U.S.C. 823(g)(2)) to permit
qualifying practitioners to seek and
obtain waivers to prescribe certain
approved controlled medications for the
treatment of opioid use disorder. The
legislation set eligibility and
certification requirements as well as an
interagency notification review process
for practitioners who seek waivers. To
implement these provisions, SAMHSA
developed Notification of Intent Forms
that facilitate the submission and review
of notifications.
On October 24, 2018, the Substance
Use Disorder Prevention that Promotes
Opioid Recovery and Treatment for
Patients and Communities (SUPPORT)
Act (Pub. L. 115–71) was signed into
law. Sections 3201–3202 of the
SUPPORT Act made several
amendments to the Controlled
Substances Act regarding office-based
opioid use disorder treatment that
affords practitioners greater flexibility in
the provision of Medications for Opioid
Use Disorder (MOUD).
The SUPPORT Act expands the
definition of ‘‘qualifying other
practitioner’’ enabling Clinical Nurse
Specialists, Certified Registered Nurse
Anesthetists, and Certified Nurse
Midwives (CNSs, CRNAs, and CNMs) to
apply for a Drug Addiction Treatment
Act of 2000 (DATA) waiver. It also
allows qualified practitioners (i.e., MDs,
DOs, NPs, PAs, CNSs, CRNAs, and
CNMs) who are board certified in
addiction medicine or addiction
psychiatry, -or- practitioners who
provide MOUD in a qualified practice
setting, to start treating up to 100
patients in the first year of MOUD
E:\FR\FM\31AUN1.SGM
31AUN1
53481
Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices
practice (as defined in 42 CFR 8.2) with
a waiver.
Further, the SUPPORT Act extends
the ability to treat up to 275 patients to
‘‘qualifying other practitioners’’ (i.e.,
NPs, PAs, CNSs, CRNAs, and CNMs) if
they have a waiver to treat up 100
patients for at least one year and
provide MOUD with covered
medications (as such terms are defined
under 42 CFR 8.2) in a qualified practice
setting as described under 42 CFR 8.615.
Finally, the SUPPORT Act also
expands how physicians could qualify
for a waiver. Under the statute now,
physicians can qualify for a waiver if
they have received at least 8 hours of
training on treating and managing
patients with opioid use disorder, as
listed in the statute if the physician
graduated in good standing from an
accredited school of allopathic medicine
or osteopathic medicine in the United
States during the 5-year period
immediately preceding the date on
which the physician submits a Notice of
Intent to SAMHSA. In order to expedite
the new provisions of the SUPPORT
Act, SAMHSA sought and received a
Public Health Emergency Paperwork
Reduction Act Waiver.
On April 28, 2021 the Department of
Health and Human Services (HHS)
issued the new Practice Guidelines for
the Administration of Buprenorphine
for Treating Opioid Use Disorder (86 FR
22439) in an expedited manner. The
new Practice Guidelines allow
42 CFR citation
Subtotal ..................
practitioners who wish to obtain a 30patient waiver to forego the 8-hour
training requirement for physicians and
24-hour training for other qualifying
practitioners. Practitioners utilizing this
training exemption are limited to
treating no more than 30-patients at a
time and time spent practicing under
this exemption will not qualify the
practitioner to qualify for a higher
patient level. In addition, the new
Practice Guidelines removed the
requirement to provide counseling and
other ancillary services (i.e.,
psychosocial services).
The collection of information within
the application is essential to the
implementation of SAMHSA’s mission
to reduce the impact of substance use
disorders on America’s communities.
Practitioners may use these forms for
various types of notifications: (a) New
Notification to treat up to 30 patients
with training or without training; (b)
New Notification, with the intent to
immediately facilitate treatment of an
individual (one) patient; (c) Second
notification of need and intent to treat
up to 100 patients; (d) New notification
to treat up to 100 patients, and (e) New
notification to treat up to 275 patients.
The forms provide the information
necessary to determine whether
practitioners meet the qualifications for
waivers set forth under the law at the
30E-, 30-, 100-, 275E-, and 275-patient
limits. This includes the annual
Estimated
number of
respondents
Purpose of submission
reporting requirements for practitioners
with waivers for a 275-patient limit.
Under ‘‘new’’ notifications,
practitioners may make their initial
waiver requests to SAMHSA.
‘‘Immediate’’ notifications inform
SAMHSA and the Attorney General of a
practitioner’s intent to prescribe
immediately to facilitate the treatment
of an individual (one) patient under 21
U.S.C. 823(g)(2)(E)(ii). The form collects
data on the following items: Practitioner
name; state medical license number;
medical specialty; and DEA registration
number; address of primary practice
location, telephone and fax numbers;
email address; purpose of notification:
new, immediate, or renewal;
certification of qualifying criteria for
treatment and management of patients
with opioid use disorder; certification of
capacity to provide directly or refer
patients for appropriate counseling and
other appropriate ancillary services, as
applicable; certification of maximum
patient load, certification to use only
those medication formulations that meet
the criteria in the law. The form also
notifies practitioners of Privacy Act
considerations and permits practitioners
to expressly consent to disclose limited
information to the SAMHSA
Buprenorphine Physician and
Behavioral Health Treatment Services
locators. The following table
summarizes the estimated annual
burden for the use of this form.
Burden/
response
(hr.)
Responses/
respondent
Total burden
(hrs.)
Notification of Intent .............................................
Notification to Prescribe Immediately ..................
Notice to Treat up to 100 patients .......................
Notice to Treat up to 275 patients .......................
1,800
60
600
960
1
1
1
1
0.083
0.083
0.04
0.081
149
5
24
78
..............................................................................
3,420
........................
........................
256
Burden Associated With the Final Rule That Increased the Patient Limit
8.620 (a)–(c) ..................
8.64 ...............................
lotter on DSK11XQN23PROD with NOTICES1
8.655 .............................
Subtotal ..................
Request for Patient Limit Increase * ....................
Request for Patient Limit Increase * ....................
Request for Patient Limit Increase * ....................
Renewal Request for a Patient Limit Increase * ..
Renewal Request for a Patient Limit Increase * ..
Renewal Request for a Patient Limit Increase * ..
Request for a Temporary Patient Increase for an
Emergency *.
Request for a Temporary Patient Increase for an
Emergency *.
Request for a Temporary Patient Increase for an
Emergency *.
620
620
620
312
312
312
12
1
1
1
1
1
1
1
0.5
0.5
0.5
0.5
0.5
0.5
3
310
310
310
156
156
156
36
12
1
3
36
12
1
3
36
..............................................................................
2,497
........................
........................
1,279
Burden Associated With the Final Rule That Outlined the Reporting Requirements
8.635 .............................
VerDate Sep<11>2014
Practitioner Reporting Form * ...............................
‘‘Qualifying Other Practitioner’’ under 21 USC
§ 823(g)(2)—Nurse Practitioners.
17:57 Aug 30, 2022
Jkt 256001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
1,620
979
E:\FR\FM\31AUN1.SGM
1
1
31AUN1
3
0.066
4,860
65
53482
Federal Register / Vol. 87, No. 168 / Wednesday, August 31, 2022 / Notices
42 CFR citation
Burden/
response
(hr.)
Responses/
respondent
Total burden
(hrs.)
‘‘Qualifying Other Practitioner’’ under 21 USC
§ 823(g)(2)—Physician Assistants.
‘‘Qualifying Other Practitioner’’ under 21 USC
§ 823(g)(2)—Certified Nurse Specialists.
‘‘Qualifying Other Practitioner’’ under 21 USC
§ 823(g)(2)—Certified Nurse Mid-Wives.
‘‘Qualifying Other Practitioner’’ under 21 USC
§ 823(g)(2)—Certified Registered Nurse Anesthetists.
708
1
0.066
47
708
1
0.066
47
708
1
0.066
47
708
1
0.066
47
Sub Total ................
..............................................................................
5,431
........................
........................
5,112
Total Burden ...
..............................................................................
6,561
........................
........................
6,647
Send comments to Carlos Graham,
SAMHSA Reports Clearance Officer,
5600 Fishers Lane, Room 15E57–A,
Rockville, Maryland 20857, OR email a
copy to Carlos.Graham@
samhsa.hhs.gov. Written comments
should be received by October 31, 2022.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022–18801 Filed 8–30–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2022–0045]
Homeland Security Advisory Council
Office of Partnership and
Engagement (OPE), Department of
Homeland Security (DHS).
ACTION: Notice of closed Federal
advisory committee meeting.
AGENCY:
The Homeland Security
Advisory Council (HSAC) will meet
virtually on Wednesday, September 14,
2022. The meeting will be closed to the
public.
DATES: The meeting will take place from
2:30 p.m. ET to 3:30 p.m. ET on
Wednesday, September 14, 2022.
Public Participation: The meeting will
be closed to the public.
FOR FURTHER INFORMATION CONTACT:
Rebecca Sternhell, Executive Director,
HSAC at 202–891–2876 or HSAC@
hq.dhs.gov.
SUMMARY:
Notice of
this meeting is given under Section
10(a) of the Federal Advisory Committee
Act (FACA), Public Law 92–463 (5
U.S.C. appendix), which requires a
portion of each FACA committee
meeting to be open to the public unless
the President, or the head of the agency
to which the advisory committee
reports, determines that a portion of the
SUPPLEMENTARY INFORMATION:
lotter on DSK11XQN23PROD with NOTICES1
Estimated
number of
respondents
Purpose of submission
VerDate Sep<11>2014
16:59 Aug 30, 2022
Jkt 256001
meeting may be closed to the public in
accordance with 5 U.S.C. 552b(c).
The HSAC provides organizationally
independent, strategic, timely, specific,
actionable advice, and
recommendations to the Secretary of
Homeland Security on matters related to
homeland security. The Council
consists of senior executives from
government, the private sector,
academia, law enforcement, and nongovernmental organizations.
The HSAC will meet in a closed
session from 2:30 p.m. to 3:30 p.m. ET
to participate in sensitive discussions
with DHS senior leadership regarding
current state of threats to the nation’s
cybersecurity and critical infrastructure.
Basis for Closure: In accordance with
section 10(d) of FACA, the Secretary of
Homeland Security has determined this
meeting must be closed during this
session as the disclosure of the
information relayed would be
detrimental to the public interest for the
following reasons:
The Council meeting will include an
operational discussion on the nation’s
cybersecurity that contains For Official
Use Only and Law Enforcement
Sensitive information. Specifically, the
Council will be briefed on DHS
operations related to threats on the
nation’s cybersecurity and efforts the
Department is taking to mitigate these
threats. Senior Leadership will provide
detailed information on the current state
of threats to the nation’s cybersecurity.
The session is closed pursuant to 5
U.S.C. 552b(c)(7) and(9)(B).
Dated: August 26, 2022.
Michael J. Miron,
Deputy Executive Director, Homeland
Security Advisory Council, Department of
Homeland Security.
[FR Doc. 2022–18819 Filed 8–30–22; 8:45 am]
BILLING CODE 9112–FN–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–7061–N–12]
60-Day Notice of Proposed Information
Collection: Public Housing Reform
Act: Changes to Admission and
Occupancy Requirements; OMB No.:
2577–0230
Office of the Assistant
Secretary for Public and Indian
Housing, HUD.
ACTION: Notice.
AGENCY:
HUD is seeking approval from
the Office of Management and Budget
(OMB) for the information collection
described below. In accordance with the
Paperwork Reduction Act, HUD is
requesting comment from all interested
parties on the proposed collection of
information. The purpose of this notice
is to allow for 60 days of public
comment.
SUMMARY:
DATES:
Comments Due Date: October 31,
2022.
Interested persons are
invited to submit comments regarding
this proposal. Comments should refer to
the proposal by name and/or OMB
Control Number and should be sent to:
Colette Pollard, Reports Management
Officer, REE, Department of Housing
and Urban Development, 451 7th Street
SW, Room 4176, Washington, DC
20410–5000; telephone 202–402–3400
(this is not a toll-free number) or email
at Colette.Pollard@hud.gov for a copy of
the proposed forms or other available
information. Persons with hearing or
speech impairments may access this
number through TTY by calling the tollfree Federal Relay Service at (800) 877–
8339.
FOR FURTHER INFORMATION CONTACT: Leea
J. Thornton, Office of Policy, Programs
and Legislative Initiatives, PIH,
Department of Housing and Urban
Development, 451 7th Street SW, Room
ADDRESSES:
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 87, Number 168 (Wednesday, August 31, 2022)]
[Notices]
[Pages 53480-53482]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18801]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-0361.
Comments are invited on: (a) whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: ``Notification of Intent To Use Schedule III, IV, or
V Controlled Medications for the Treatment of Opioid Use Disorder''
Under 21 U.S.C. 823(g)(2) (OMB No. 0930-0234 and OMB No. 0930-0369)--
Revision
The Drug Addiction Treatment Act of 2000 (``DATA,'' Pub. L. 106-
310) amended the Controlled Substances Act (21 U.S.C. 823(g)(2)) to
permit qualifying practitioners to seek and obtain waivers to prescribe
certain approved controlled medications for the treatment of opioid use
disorder. The legislation set eligibility and certification
requirements as well as an interagency notification review process for
practitioners who seek waivers. To implement these provisions, SAMHSA
developed Notification of Intent Forms that facilitate the submission
and review of notifications.
On October 24, 2018, the Substance Use Disorder Prevention that
Promotes Opioid Recovery and Treatment for Patients and Communities
(SUPPORT) Act (Pub. L. 115-71) was signed into law. Sections 3201-3202
of the SUPPORT Act made several amendments to the Controlled Substances
Act regarding office-based opioid use disorder treatment that affords
practitioners greater flexibility in the provision of Medications for
Opioid Use Disorder (MOUD).
The SUPPORT Act expands the definition of ``qualifying other
practitioner'' enabling Clinical Nurse Specialists, Certified
Registered Nurse Anesthetists, and Certified Nurse Midwives (CNSs,
CRNAs, and CNMs) to apply for a Drug Addiction Treatment Act of 2000
(DATA) waiver. It also allows qualified practitioners (i.e., MDs, DOs,
NPs, PAs, CNSs, CRNAs, and CNMs) who are board certified in addiction
medicine or addiction psychiatry, -or- practitioners who provide MOUD
in a qualified practice setting, to start treating up to 100 patients
in the first year of MOUD
[[Page 53481]]
practice (as defined in 42 CFR 8.2) with a waiver.
Further, the SUPPORT Act extends the ability to treat up to 275
patients to ``qualifying other practitioners'' (i.e., NPs, PAs, CNSs,
CRNAs, and CNMs) if they have a waiver to treat up 100 patients for at
least one year and provide MOUD with covered medications (as such terms
are defined under 42 CFR 8.2) in a qualified practice setting as
described under 42 CFR 8.615.
Finally, the SUPPORT Act also expands how physicians could qualify
for a waiver. Under the statute now, physicians can qualify for a
waiver if they have received at least 8 hours of training on treating
and managing patients with opioid use disorder, as listed in the
statute if the physician graduated in good standing from an accredited
school of allopathic medicine or osteopathic medicine in the United
States during the 5-year period immediately preceding the date on which
the physician submits a Notice of Intent to SAMHSA. In order to
expedite the new provisions of the SUPPORT Act, SAMHSA sought and
received a Public Health Emergency Paperwork Reduction Act Waiver.
On April 28, 2021 the Department of Health and Human Services (HHS)
issued the new Practice Guidelines for the Administration of
Buprenorphine for Treating Opioid Use Disorder (86 FR 22439) in an
expedited manner. The new Practice Guidelines allow practitioners who
wish to obtain a 30-patient waiver to forego the 8-hour training
requirement for physicians and 24-hour training for other qualifying
practitioners. Practitioners utilizing this training exemption are
limited to treating no more than 30-patients at a time and time spent
practicing under this exemption will not qualify the practitioner to
qualify for a higher patient level. In addition, the new Practice
Guidelines removed the requirement to provide counseling and other
ancillary services (i.e., psychosocial services).
The collection of information within the application is essential
to the implementation of SAMHSA's mission to reduce the impact of
substance use disorders on America's communities. Practitioners may use
these forms for various types of notifications: (a) New Notification to
treat up to 30 patients with training or without training; (b) New
Notification, with the intent to immediately facilitate treatment of an
individual (one) patient; (c) Second notification of need and intent to
treat up to 100 patients; (d) New notification to treat up to 100
patients, and (e) New notification to treat up to 275 patients. The
forms provide the information necessary to determine whether
practitioners meet the qualifications for waivers set forth under the
law at the 30E-, 30-, 100-, 275E-, and 275-patient limits. This
includes the annual reporting requirements for practitioners with
waivers for a 275-patient limit.
Under ``new'' notifications, practitioners may make their initial
waiver requests to SAMHSA. ``Immediate'' notifications inform SAMHSA
and the Attorney General of a practitioner's intent to prescribe
immediately to facilitate the treatment of an individual (one) patient
under 21 U.S.C. 823(g)(2)(E)(ii). The form collects data on the
following items: Practitioner name; state medical license number;
medical specialty; and DEA registration number; address of primary
practice location, telephone and fax numbers; email address; purpose of
notification: new, immediate, or renewal; certification of qualifying
criteria for treatment and management of patients with opioid use
disorder; certification of capacity to provide directly or refer
patients for appropriate counseling and other appropriate ancillary
services, as applicable; certification of maximum patient load,
certification to use only those medication formulations that meet the
criteria in the law. The form also notifies practitioners of Privacy
Act considerations and permits practitioners to expressly consent to
disclose limited information to the SAMHSA Buprenorphine Physician and
Behavioral Health Treatment Services locators. The following table
summarizes the estimated annual burden for the use of this form.
----------------------------------------------------------------------------------------------------------------
Estimated
42 CFR citation Purpose of number of Responses/ Burden/ Total burden
submission respondents respondent response (hr.) (hrs.)
----------------------------------------------------------------------------------------------------------------
Notification of 1,800 1 0.083 149
Intent.
Notification to 60 1 0.083 5
Prescribe
Immediately.
Notice to Treat 600 1 0.04 24
up to 100
patients.
Notice to Treat 960 1 0.081 78
up to 275
patients.
---------------------------------------------------------------
Subtotal.................. ................ 3,420 .............. .............. 256
----------------------------------------------------------------------------------------------------------------
Burden Associated With the Final Rule That Increased the Patient Limit
----------------------------------------------------------------------------------------------------------------
8.620 (a)-(c)................. Request for 620 1 0.5 310
Patient Limit
Increase *.
Request for 620 1 0.5 310
Patient Limit
Increase *.
Request for 620 1 0.5 310
Patient Limit
Increase *.
8.64.......................... Renewal Request 312 1 0.5 156
for a Patient
Limit Increase
*.
Renewal Request 312 1 0.5 156
for a Patient
Limit Increase
*.
Renewal Request 312 1 0.5 156
for a Patient
Limit Increase
*.
8.655......................... Request for a 12 1 3 36
Temporary
Patient
Increase for an
Emergency *.
Request for a 12 1 3 36
Temporary
Patient
Increase for an
Emergency *.
Request for a 12 1 3 36
Temporary
Patient
Increase for an
Emergency *.
---------------------------------------------------------------
Subtotal.................. ................ 2,497 .............. .............. 1,279
----------------------------------------------------------------------------------------------------------------
Burden Associated With the Final Rule That Outlined the Reporting Requirements
----------------------------------------------------------------------------------------------------------------
8.635......................... Practitioner 1,620 1 3 4,860
Reporting Form
*.
``Qualifying 979 1 0.066 65
Other
Practitioner''
under 21 USC
Sec.
823(g)(2)--Nurs
e Practitioners.
[[Page 53482]]
``Qualifying 708 1 0.066 47
Other
Practitioner''
under 21 USC
Sec.
823(g)(2)--Phys
ician
Assistants.
``Qualifying 708 1 0.066 47
Other
Practitioner''
under 21 USC
Sec.
823(g)(2)--Cert
ified Nurse
Specialists.
``Qualifying 708 1 0.066 47
Other
Practitioner''
under 21 USC
Sec.
823(g)(2)--Cert
ified Nurse Mid-
Wives.
``Qualifying 708 1 0.066 47
Other
Practitioner''
under 21 USC
Sec.
823(g)(2)--Cert
ified
Registered
Nurse
Anesthetists.
---------------------------------------------------------------
Sub Total................. ................ 5,431 .............. .............. 5,112
---------------------------------------------------------------
Total Burden.......... ................ 6,561 .............. .............. 6,647
----------------------------------------------------------------------------------------------------------------
Send comments to Carlos Graham, SAMHSA Reports Clearance Officer,
5600 Fishers Lane, Room 15E57-A, Rockville, Maryland 20857, OR email a
copy to [email protected]. Written comments should be
received by October 31, 2022.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022-18801 Filed 8-30-22; 8:45 am]
BILLING CODE 4162-20-P
